Scott R Solomon

10PUBLICATIONS
60CO-AUTHORS
Liquid biopsiesLanguage documentation and descriptionCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Nutritional epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 27, 2026
Circulating Tumor DNA Assessment of Disease Response in Large B-Cell Lymphoma: Lisocabtagene Maraleucel Versus Autologous Stem Cell Transplantation Standard Therapy.

|Jul 07, 2025
Lisocabtagene Maraleucel Versus Standard of Care for Second-Line Relapsed/Refractory Large B-Cell Lymphoma: 3-Year Follow-Up From the Randomized, Phase III TRANSFORM Study.

Manali Kamdar, Scott R Solomon, Jon Arnason

|Sep 19, 2024
Intrathecal chemotherapy as treatment for chimeric antigen receptor T cell (CAR T) therapy associated neurotoxicity.

Saffiya Z Bashey, Scott R Solomon, Xu Zhang

|Jul 31, 2024
HLA evolutionary divergence (HED) informs the effect of HLA-B mismatch on outcomes after haploidentical transplantation.

Melhem Solh, Michael T Aubrey, Xu Zhang

|Jan 23, 2024
Letermovir prophylaxis lowers the incidence of Non-CMV infections after allogeneic hematopoietic cell transplantation.

Saffiya Z Bashey, Scott R Solomon, Xu Zhang

|Dec 10, 2023
Lisocabtagene Maraleucel in Relapsed/Refractory Mantle Cell Lymphoma: Primary Analysis of the Mantle Cell Lymphoma Cohort From TRANSCEND NHL 001, a Phase I Multicenter Seamless Design Study.

Michael Wang, Tanya Siddiqi, Leo I Gordon

Pageof 2

Frequent Collaborators

4 joint publications

Melhem Solh

3 joint publications

Jeremy S Abramson

2 joint publications

Manali Kamdar

2 joint publications

Stephan Mielke